At the time of the baseline evaluation, the majority of patients with ATTR-CM had symptoms of HF and markedly elevated cardiac biomarkers (median troponin T 53 ng/L (IQR 28–82) and median NT-proBNP 2033 pg/mL (IQR 1278–3572)). Here, NPPB is linked to cutaneous mastocytosis.